This trial will test whether switching to the study's investigational products (IPs) is safer for generally healthy smokers than continuing to smoke, undergoing smoking abstinence, or never having smoked.
11 Primary · 0 Secondary · Reporting Duration: 180 days
1885 Total Participants · 8 Treatment Groups
Primary Treatment: Product B: Non-Combusted Cigarette Variant 42001399 and product use Mode B · No Placebo Group · N/A
Age 18 - 65 · All Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
|18 - 65||100.0%|
|Woodland Research Northwest||50.0%|
|Bright Research Center||50.0%|